Characterization of Nestin, a Selective Marker for Bone Marrow Derived Mesenchymal Stem Cells

Stem Cells International

Volumn 2015, Issue , 2015, Pages

  Xie, Liang ^a   Zeng, Xin ^a   Hu, Jing ^a   Chen, Qianming ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MARKER; NESTIN;

AMINO TERMINAL SEQUENCE; ANGIOGENESIS; BONE DEVELOPMENT; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CARBOXY TERMINAL SEQUENCE; CELL ACTIVITY; CELL DIFFERENTIATION; CELL RENEWAL; DISEASE ASSOCIATION; MYELOPROLIFERATIVE NEOPLASM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; STRUCTURE ACTIVITY RELATION;

NES;

EID: 84937707399     PISSN: None     EISSN: 16879678     Source Type: Journal    
DOI: 10.1155/2015/762098     Document Type: Review

References (116)

1. C. R. Cogle, S. M. Guthrie, R. C. Sanders, W. L. Allen, E. W. Scott, and B. E. Petersen, "An overview of stemcell research and regulatory issues," Mayo Clinic Proceedings, vol. 78, no. 8, pp. 993-1003, 2003.
2. D. L. Clarke, C. B. Johansson, J. Wilbertz et al., "Generalized potential of adult neural stem cells," Science, vol. 288, no. 5471, pp. 1660-1663, 2000.
3. J.W. Goodman, "Stemcells of the hematopoietic and lymphatic tissues," National Cancer Institute Monograph, vol. 14, pp. 151-168, 1964.
4. B. E. Grottkau, P. P. Purudappa, and Y.-F. Lin, "Multilineage differentiation of dental pulp stem cells from green fluorescent protein transgenic mice," International Journal of Oral Science, vol. 2, no. 1, pp. 21-27, 2010.
5. L. Peng, L. Ye, and X.-D. Zhou, "Mesenchymal stem cells and tooth engineering," International Journal of Oral Science, vol. 1, no. 1, pp. 6-12, 2009.
6. U. Technau and C. B. Scholz, "Origin and evolution of endodermandmesoderm," The International Journal of Developmental Biology, vol. 47, no. 7-8, pp. 531-539, 2003.
7. D. Kimelman, "Mesoderm induction: from caps to chips," Nature Reviews Genetics, vol. 7, no. 5, pp. 360-372, 2006.
8. M. Reyes, T. Lund, T. Lenvik, D. Aguiar, L. Koodie, and C. M. Verfaillie, "Purification and ex vivo expansion of postnatal humanmarrowmesodermal progenitor cells," Blood, vol. 98,pp. 2615-2625, 2001.
9. M. F. Pittenger, "Multilineage potential of adult human mesenchymal stem cells," Science, vol. 284, pp. 143-147, 1999.
10. A. Uccelli, L. Moretta, and V. Pistoia, "Mesenchymal stem cells in health and disease," Nature Reviews Immunology, vol. 8, no. 9, pp. 726-736, 2008.
11. M. Dominici, K. Le Blanc, I. Mueller et al., "Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for CellularTherapy position statement," Cytotherapy, vol. 8, no. 4, pp. 315-317, 2006.
12. A. I. Caplan, "Mesenchymal stem cells," Journal of Orthopaedic Research, vol. 9, no. 5, pp. 641-650, 1991.
13. S. Carlson, J. Trial, C. Soeller, and M. L. Entman, "Cardiac mesenchymal stem cells contribute to scar formation after myocardial infarction," Cardiovascular Research, vol. 91, no. 1, pp. 99-107, 2011.
14. R. F. Foronjy and S. M. Majka, "The potential for resident lung mesenchymal stem cells to promote functional tissue regeneration: understanding microenvironmental cues," Cells, vol. 1, no. 4, pp. 874-885, 2012.
15. D.-W. Kim, M. Staples, K. Shinozuka, P. Pantcheva, S.-D. Kang, and C. V. Borlongan, "Wharton's jelly-derived mesenchymal stem cells: phenotypic characterization and optimizing their therapeutic potential for clinical applications," International Journal ofMolecular Sciences, vol. 14,no. 6, pp. 11692-11712, 2013.
16. P.-P. Chong, L. Selvaratnam, A. A. Abbas, and T. Kamarul, "Human peripheral blood derived mesenchymal stem cells demonstrate similar characteristics and chondrogenic differentiation potential to bone marrow derived mesenchymal stem cells," Journal of Orthopaedic Research, vol. 30, no. 4, pp. 634-642, 2012.
17. A. Banas, "Purification of adipose tissue mesenchymal stem cells and differentiation toward hepatic-like cells," Methods in Molecular Biology, vol. 826, pp. 61-72, 2012.
18. A. I. Caplan, "Adultmesenchymal stem cells for tissue engineering versus regenerative medicine," Journal of Cellular Physiology, vol. 213, no. 2, pp. 341-347, 2007.
19. D. T. Harris, "Umbilical cord tissue mesenchymal stem cells: characterization and clinical applications," Current Stem Cell Research &Therapy, vol. 8, no. 5, pp. 394-399, 2013.
20. U. Lendahl, L. B. Zimmerman, and R. D. G.McKay, "CNS stem cells express a new class of intermediate filament protein," Cell, vol. 60, no. 4, pp. 585-595, 1990.
21. J. Dahlstrand, M. Lardelli, and U. Lendahl, "Nestin mRNA expression correlates with the central nervous system progenitor cell state in many, but not all, regions of developing central nervous system," Developmental Brain Research, vol. 84, no. 1, pp. 109-129, 1995.
22. C. G. Di, A. P. Xiang, L. Jia, J. F. Liu, B. T. Lahn, and B. F. Ma, "Involvement of extracellular factors in maintaining selfrenewal of neural stem cell by nestin," NeuroReport, vol. 25, no. 10, pp. 782-787, 2014.
23. S. Suzuki, J. Namiki, S. Shibata, Y. Mastuzaki, and H. Okano, "The neural stem/progenitor cell marker nestin is expressed in proliferative endothelial cells, but not in mature vasculature," The Journal of Histochemistry and Cytochemistry, vol. 58, no. 8, pp. 721-730, 2010.
24. O. Krupkova Jr., T. Loja, I. Zambo, and R. Veselska, "Nestin expression in human tumors and tumor cell lines," Neoplasma, vol. 57, no. 4, pp. 291-298, 2010.
25. Y. Kishaba, D. Matsubara, and T. Niki, "Heterogeneous expression of nestin in myofibroblasts of various human tissues," Pathology International, vol. 60, no. 5, pp. 378-385, 2010.
26. S. Abe, K. Hamada, M. Miura, and S. Yamaguchi, "Neural crest stem cell property of apical pulp cells derived from human developing tooth," Cell Biology International, vol. 36, no. 10, pp. 927-936, 2012.
27. K. Du, Y. Peng, L. Zhang, A. Liang, and D. Huang, "Expression of the stemcellmarker nestin inpre/hypertrophic chondrocytes in osteochondroma," Journal of InternationalMedical Research, vol. 39, no. 2, pp. 348-357, 2011.
28. C. Wiese, A. Rolletschek, G. Kania et al., "Nestin expression - a property of multi-lineage progenitor cells?" Cellular and Molecular Life Sciences, vol. 61, no. 19-20, pp. 2510-2522, 2004.
29. H. Zulewski, E. J. Abraham, M. J. Gerlach et al., "Multipotential nestin-positive stem cells isolated from adult pancreatic islets differentiate ex vivo into pancreatic endocrine, exocrine, and hepatic phenotypes," Diabetes, vol. 50, no. 3, pp. 521-533, 2001.
30. Y. Kunisaki, I. Bruns, C. Scheiermann et al., "Arteriolar niches maintain haematopoietic stem cell quiescence," Nature, vol. 502, no. 7473, pp. 637-643, 2013.
31. S.Méndez-Ferrer, T. V.Michurina, F. Ferraro et al., "Mesenchymal and haematopoietic stem cells form a unique bone marrow niche," Nature, vol. 466, no. 7308, pp. 829-834, 2010.
32. A.Mendelson and P. S. Frenette, "Hematopoietic stemcell niche maintenance during homeostasis and regeneration," Nature Medicine, vol. 20, no. 8, pp. 833-846, 2014.
33. N. Ono, W. Ono, T. Mizoguchi, T. Nagasawa, P. S. Frenette, and H. M. Kronenberg, "Vasculature-associated cells expressing nestin in developing bones encompass early cells in the osteoblast and endothelial lineage," Developmental Cell, vol. 29, no. 3, pp. 330-339, 2014.
34. Y. Matsuda, M. Hagio, and T. Ishiwata, "Nestin: a novel angiogenesis marker and possible target for tumor angiogenesis," World Journal of Gastroenterology, vol. 19, no. 1, pp. 42-48, 2013.
35. P. M. Steinert and R. K. H. Liem, "Intermediate filament dynamics," Cell, vol. 60, no. 4, pp. 521-523, 1990.
36. K. Michalczyk and M. Ziman, "Nestin structure and predicted function in cellular cytoskeletal organisation," Histology and Histopathology, vol. 20, no. 2, pp. 665-671, 2005.
37. A. Karabinos, D. Riemer, A. Erber, and K.Weber, "Homologues of vertebrate type I, II and III intermediate filament (IF) proteins in an invertebrate: the IF multigene family of the cephalochordate Branchiostoma," FEBS Letters, vol. 437, no. 1-2, pp. 15-18, 1998.
38. H. Herrmann, H. Bär, L. Kreplak, S. V. Strelkov, and U. Aebi, "Intermediate filaments: fromcell architecture to nanomechanics," Nature ReviewsMolecular Cell Biology, vol. 8, no. 7,pp. 562-573, 2007.
39. D. Guérette, P. A. Khan, P. E. Savard, and M. Vincent, "Molecular evolution of type VI intermediate filament proteins," BMC Evolutionary Biology, vol. 7, article 164, 2007.
40. N. J. Buchkovich, W. M. Henne, S. Tang, and S. D. Emr, "Essential N-Terminal insertion motif anchors the ESCRT-III filament during MVB vesicle formation," Developmental Cell, vol. 27, no. 2, pp. 201-214, 2013.
41. P. M. Steinert, Y.-H. Chou, V. Prahlad et al., "A high molecular weight intermediate filament-associated protein in BHK-21 cells is nestin, a type VI intermediate filament protein. Limited co-assembly in vitro to form heteropolymers with type III vimentin and type IV alpha-internexin," The Journal of Biological Chemistry, vol. 274, no. 14, pp. 9881-9890, 1999.
42. M. J. Marvin, J. Dahlstrand, U. Lendahl, and R. D. G. McKay, "A rod end deletion in the intermediate filament protein nestin alters its subcellular localization in neuroepithelial cells of transgenic mice," Journal of Cell Science, vol. 111, no. 14, pp. 1951-1961, 1998.
43. C. M. Sahlgren, A. Mikhailov, J. Hellman et al., "Mitotic reorganization of the intermediate filament protein nestin involves phosphorylation by cdc2 kinase," Journal of Biological Chemistry, vol. 276, no. 19, pp. 16456-16463, 2001.
44. E. Schipani and H. M. Kronenberg, "Adult mesenchymal stem cells," in StemBook, Harvard Stem Cell Institute, Cambridge, Mass, USA, 2008.
45. S. A. Boxall and E. Jones, "Markers for characterization of bone marrow multipotential stromal cells," Stem Cells International, vol. 2012, Article ID975871, 12 pages, 2012.
46. T. Tondreau, L. Lagneaux, M. Dejenefle et al., "Bone marrowderived mesenchymal stem cells already express specific neural proteins before any differentiation," Differentiation, vol. 72, no. 7, pp. 319-326, 2004.
47. J. Isern and S. Méndez-Ferrer, "Stem cell interactions in a bone marrow niche," Current Osteoporosis Reports, vol. 9, no. 4, pp. 210-218, 2011.
48. S. Pillozzi and A. Becchetti, "Ion channels in hematopoietic and mesenchymal stem cells," Stem Cells International, vol. 2012, Article ID 217910, 9 pages, 2012.
49. S. Pinho, J. Lacombe, M. Hanoun et al., "PDGFRγ and CD51 mark human Nestin+ sphere-forming mesenchymal stem cells capable of hematopoietic progenitor cell expansion," The Journal of ExperimentalMedicine, vol. 210, no. 7, pp. 1351-1367, 2013.
50. M. Crisan, S. Yap, L. Casteilla et al., "A perivascular origin for mesenchymal stem cells in multiple human organs," Cell Stem Cell, vol. 3, no. 3, pp. 301-313, 2008.
51. G. Lin, G. Liu, L. Banie et al., "Tissue distribution ofmesenchymal stem cell marker stro-1," Stem Cells and Development, vol. 20, no. 10, pp. 1747-1752, 2011.
52. H. Ning, G. Lin, T. F. Lue, and C.-S. Lin, "Mesenchymal stem cell marker Stro-1 is a 75 kd endothelial antigen," Biochemical and Biophysical Research Communications, vol. 413, no. 2, pp. 353-357, 2011.
53. S. B. Bradfute, T. A. Graubert, andM. A. Goodell, "Roles of Sca-1 in hematopoietic stem/progenitor cell function," Experimental Hematology, vol. 33, no. 7, pp. 836-843, 2005.
54. C. Grange, S. Lanzardo, F. Cavallo,G. Camussi, and B. Bussolati, "SCA-1 identifies the tumor-initiating cells in mammary tumors of BALB-neuT trangenic mice," Neoplasia, vol. 10, no. 12, pp. 1433-1443, 2008.
55. N. Haraguchi, H. Ishii, K. Mimori et al., "CD13 is a therapeutic target in human liver cancer stem cells,"The Journal of Clinical Investigation, vol. 120, no. 9, pp. 3326-3339, 2010.
56. E. Dondossola, R. Rangel, L. Guzman-Rojas et al., "CD13-positive bone marrow-derivedmyeloid cells promote angiogenesis, tumor growth, and metastasis," Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 51, pp. 20717-20722, 2013.
57. J. Pruszak, W. Ludwig, A. Blak, K. Alavian, and O. Isacson, "CD15, CD24, and CD29 define a surface biomarker code for neural lineage differentiation of stem cells," Stem Cells, vol. 27, no. 12, pp. 2928-2940, 2009.
58. S.Geng, Y. Guo, Q.Wang, L. Li, and J.Wang, "Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial-mesenchymal transition in squamous cell carcinoma," Archives of Dermatological Research, vol. 305, no. 1, pp. 35-47, 2013.
59. B. J. G. Baaten, C.-R. Li, and L. M. Bradley, "Multifaceted regulation of T cells by CD44," Communicative & Integrative Biology, vol. 3, no. 6, pp. 508-512, 2010.
60. T. Hiraga, S. Ito, and H. Nakamura, "Cancer stem-like cell marker CD44 promotes bone metastases by enhancing tumorigenicity, cell motility, and hyaluronan production," Cancer Research, vol. 73, no. 13, pp. 4112-4122, 2013.
61. F. F. De Beca, P. Caetano, R. Gerhard et al., "Cancer stem cells markers CD44, CD24 and ALDH1 in breast cancer special histological types," Journal of Clinical Pathology, vol. 66, no. 3, pp. 187-191, 2013.
62. S. Narravula, P. F. Lennon, B. U. Mueller, and S. P. Colgan, "Regulation of endothelial CD73 by adenosine: paracrine pathway for enhanced endothelial barrier function," The Journal of Immunology, vol. 165, no. 9, pp. 5262-5268, 2000.
63. J. H. Mills, L. F. Thompson, C. Mueller et al., "CD73 is required for efficient entry of lymphocytes into the central nervous system during experimental autoimmune encephalomyelitis," Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 27, pp. 9325-9330, 2008.
64. T. A. Rege and J. S. Hagood, "Thy-1 as a regulator of cell-cell and cell-matrix interactions in axon regeneration, apoptosis, adhesion, migration, cancer, and fibrosis," The FASEB Journal, vol. 20, no. 8, pp. 1045-1054, 2006.
65. L. Pierelli, G. Bonanno, S. Rutella, M. Marone, G. Scambia, and G. Leone, "CD105 (endoglin) expression on hematopoietic stem/progenitor cells," Leukemia & Lymphoma, vol. 42, no. 6, pp. 1195-1206, 2001.
66. H. Yoshitomi, S. Kobayashi, M. Ohtsuka et al., "Specific expression of endoglin (CD105) in endothelial cells of intratumoral blood and lymphatic vessels in pancreatic cancer," Pancreas, vol. 37, no. 3, pp. 275-281, 2008.
67. S. Ren, X. Fan, L. Peng et al., "Expression of NF-κB, CD68 and CD105 in carotid atherosclerotic plaque," Journal of Thoracic Disease, vol. 5, no. 6, pp. 771-776, 2013.
68. J. Heidemann, C. Maaser, A. Lügering et al., "Expression of vascular cell adhesion molecule-1 (CD 106) in normal and neoplastic human esophageal squamous epithelium," International Journal of Oncology, vol. 28, no. 1, pp. 77-85, 2006.
69. A. V. Hadjinicolaou, L. Wu, B. Fang, P. A. Watson, F. C. Hall, and R. Busch, "Relationship of CD146 expression to activation of circulating T cells: exploratory studies in healthy donors and patients with connective tissue diseases," Clinical and Experimental Immunology, vol. 174, no. 1, pp. 73-88, 2013.
70. I. R. Murray, C. C. West, W. R. Hardy et al., "Natural history ofmesenchymal stemcells, fromvessel walls to culture vessels," Cellular andMolecular Life Sciences, vol. 71, no. 8, pp. 1353-1374, 2014.
71. Q. Li, Y. Yu, J. Bischoff, J. B. Mulliken, and B. R. Olsen, "Differential expression of CD146 in tissues and endothelial cells derived from infantile haemangioma and normal human skin,"TheJournal of Pathology, vol. 201, no. 2,pp. 296-302, 2003.
72. H. Fujiwara, K. Tatsumi, K. Kosaka et al., "Human blastocysts and endometrial epithelial cells express activated leukocyte cell adhesion molecule (ALCAM/CD166),"The Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 7, pp. 3437-3443, 2003.
73. S.M.A.Abidi, M. K. Saifullah, M. D. Zafiropulos et al., "CD166 expression, characterization, and localization in salivary epithelium: implications for function during sialoadenitis," Journal of Clinical Immunology, vol. 26, no. 1, pp. 12-21, 2006.
74. E.Dupin and J. M.Coelho-Aguiar, "Isolation and differentiation properties of neural crest stem cells," Cytometry Part A, vol. 83, no. 1, pp. 38-47, 2013.
75. A. D. Boiko, O. V. Razorenova, M. van de Rijn et al., "Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271," Nature, vol. 466, pp. 133-137, 2010.
76. N. Erez, M. Truitt, P. Olson, and D. Hanahan, "Cancerassociated fibroblasts are activated in incipient neoplasia to orchestrate tumor-promoting inflammation in an NF-κB dependent manner," Cancer Cell, vol. 17, no. 2, pp. 135-147, 2010.
77. Y. Hu, G. Böck, G. Wick, and Q. Xu, "Activation of PDGF receptor alpha in vascular smooth muscle cells by mechanical stress," The FASEB Journal, vol. 12, no. 12, pp. 1135-1142, 1998.
78. D. Kielar, J. S. C. Clark, A. Ciechanowicz, G. Kurzawski, T. Sulikowski, and M. Naruszewicz, "Leptin receptor isoforms expressed in human adipose tissue," Metabolism: Clinical and Experimental, vol. 47, no. 7, pp. 844-847, 1998.
79. D. Lucas, I. Bruns, M. Battista et al., "Norepinephrine reuptake inhibition promotes mobilization in mice: potential impact to rescue lowstemcell yields," Blood, vol. 119, no. 17, pp. 3962-3965, 2012.
80. L. Ding, T. L. Saunders, G. Enikolopov, and S. J. Morrison, "Endothelial and perivascular cells maintain haematopoietic stem cells," Nature, vol. 481, no. 7382, pp. 457-462, 2012.
81. F. Tronche, C. Kellendonk, O. Kretz et al., "Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety,"NatureGenetics, vol. 23,no. 1, pp.99-103, 1999.
82. T. Mizoguchi, S. Pinho, J. Ahmed et al., "Osterix marks distinct waves of primitive and definitive stromal progenitors during bone marrow development," Developmental Cell, vol. 29, no. 3, pp. 340-349, 2014.
83. J. Isern, A. GarcÍa-GarcÍa, A. M. MartÍn et al., "The neural crest is a source of mesenchymal stem cells with specialized hematopoietic stem cell niche function," eLife, vol. 3, Article ID e03696, 2014.
84. J. Oswald, S. Boxberger, B. Jorgensen et al., "Mesenchymal stem cells can be differentiated into endothelial cells in vitro," Stem Cells, vol. 22, no. 3, pp. 377-384, 2004.
85. M. Jazayeri,A.Allameh,M. Soleimani, S.H. Jazayeri,A. Piryaei, and S. Kazemnejad, "Molecular and ultrastructural characterization of endothelial cells differentiated from human bone marrow mesenchymal stem cells," Cell Biology International, vol. 32, no. 10, pp. 1183-1192, 2008.
86. J. W. Liu, S. Dunoyer-Geindre, V. Serre-Beinier et al., "Characterization of endothelial-like cells derived from human mesenchymal stem cells," Journal of Thrombosis and Haemostasis, vol. 5, no. 4, pp. 826-834, 2007.
87. S.G.Ball, J. J.Worthington, A. E. Canfield, C. L. R.Merry, andC. M. Kielty, "Mesenchymal stromal cells: inhibiting PDGF receptors or depleting fibronectin induces mesodermal progenitors with endothelial potential," Stem Cells, vol. 32, no. 3, pp. 694-705, 2014.
88. D. Henrich, K. Wilhelm, J. Warzecha et al., "Human endothelial-like differentiated precursor cells maintain their endothelial characteristics when cocultured with mesenchymal stem cell and seeded onto human cancellous bone," Mediators of Inflammation, vol. 2013,Article ID 364591, 12 pages, 2013.
89. D. Klein, N. Meissner, V. Kleff, H. Jastrow, M. Yamaguchi, and V. Jendrossek, "Nestin(+) tissue-resident multipotent stem cells contribute to tumor progression by differentiating into pericytes and smooth muscle cells resulting in blood vessel remodeling," Frontiers in Oncology, vol. 4, article 169, 2014.
90. J. Mokrý and S.Němeček, "Cerebral angiogenesis shows nestin expression in endothelial cells," General Physiology and Biophysics, vol. 18, supplement 1, pp. 25-29, 1999.
91. K. Yamahatsu, Y.Matsuda, T. Ishiwata, E. Uchida, and Z. Naito, "Nestin as a novel therapeutic target for pancreatic cancer via tumor angiogenesis," International Journal of Oncology, vol. 40, no. 5, pp. 1345-1357, 2012.
92. V. El-Helou, P. C. Beguin, J. Assimakopoulos et al., "The rat heart contains a neural stem cell population; Role in sympathetic sprouting and angiogenesis," Journal of Molecular and Cellular Cardiology, vol. 45, no. 5, pp. 694-702, 2008.
93. K.-I. Sugawara, H. Kurihara, M. Negishi et al., "Nestin as a marker for proliferative endothelium in gliomas," Laboratory Investigation, vol. 82, no. 3, pp. 345-351, 2002.
94. H. You, Y. I. Kim, S. Y. Im et al., "Immunohistochemical study of central neurocytoma, subependymoma, and subependymal giant cell astrocytoma," Journal of Neuro-Oncology, vol. 74, no. 1, pp. 1-8, 2005.
95. R. Veselska, M. Hermanova, T. Loja et al., "Nestin expression in osteosarcomas and derivation of nestin/CD133 positive osteosarcoma cell lines," BMC Cancer, vol. 8, article 300, 2008.
96. T. Ishiwata, Y.Matsuda, andZ.Naito, "Nestin in gastrointestinal and other cancers: effects on cells and tumor angiogenesis," World Journal of Gastroenterology, vol. 17, no. 4, pp. 409-418, 2011.
97. N. Teranishi, Z. Naito, T. Ishiwata et al., "Identification of neovasculature using nestin in colorectal cancer," International Journal of Oncology, vol. 30, no. 3, pp. 593-603, 2007.
98. P. Bianco, X. Cao, P. S. Frenette et al., "Themeaning, the sense and the significance: translating the science of mesenchymal stem cells intomedicine," Nature Medicine, vol. 19, no. 1, pp. 35-42, 2013.
99. P. Au, J. Tam, D. Fukumura, and R. K. Jain, "Bone marrowderived mesenchymal stem cells facilitate engineering of longlasting functional vasculature," Blood, vol. 111, no. 9, pp. 4551-4558, 2008.
100. M. Petrini, S. Pacini, L. Trombi et al., "Identification and purification of mesodermal progenitor cells from human adult bone marrow," Stem Cells and Development, vol. 18, no. 6, pp. 857-866, 2009.
101. S. Pacini, V. Carnicelli, L. Trombi et al., "Constitutive expression of pluripotency-associated genes in mesodermal progenitor cells (MPCs)," PLoS ONE, vol. 5, no. 3,Article ID e9861, 2010.
102. S. Pacini and I. Petrini, "Are MSCs angiogenic cells? New insights on human nestin-positive bone marrow-derived multipotent cells," Frontiers in Cell and Developmental Biology, vol. 2, article 20, 2014.
103. J. L. Crane and X. Cao, "Bone marrow mesenchymal stem cells and TGF-β signaling in bone remodeling," The Journal of Clinical Investigation, vol. 124, no. 2, pp. 466-472, 2014.
104. G. Zhen, C. Wen, X. Jia et al., "Inhibition of TGF-β signaling in mesenchymal stem cells of subchondral bone attenuates osteoarthritis," Nature Medicine, vol. 19,no. 6, pp. 704-712, 2013.
105. M. Hanoun, D. Zhang, T. Mizoguchi et al., "Acute myelogenous leukemia-induced sympathetic neuropathy promotes malignancy in an altered hematopoietic stem cell niche," Cell Stem Cell, vol. 15, no. 3, pp. 365-375, 2014.
106. L. Arranz, A. Sánchez-Aguilera, D. MartÍn-Pérez et al., "Neuropathy of haematopoietic stem cell niche is essential for myeloproliferative neoplasms," Nature, vol. 512, no. 1, pp. 78-81, 2014.
107. N. Baryawno and D. T. Scadden, "Blood loses it when nerves go bad," Cell Research, vol. 24, pp. 1151-1152, 2014.
108. P. Gao, Y. Zhou, L. Xian et al., "Functional effects of TGF-β1 on mesenchymal stem cell mobilization in cockroach allergeninduced asthma," Journal of Immunology, vol. 192, no. 10, pp. 4560-4570, 2014.
109. M. Wan, C. Li, G. Zhen et al., "Injury-activated transforming growth factor β controls mobilization of mesenchymal stem cells for tissue remodeling," Stem Cells, vol. 30, no. 11, pp. 2498-2511, 2012.
110. A.Wong, E. Ghassemi, and C. E. Yellowley, "Nestin expression in mesenchymal stromal cells: Regulation by hypoxia and osteogenesis,"BMCVeterinary Research, vol. 10, article 173, 2014.
111. S.Wislet-Gendebien, E. Laudet, V. Neirinckx et al., "Mesenchymal stem cells and neural crest stem cells from adult bone marrow: characterization of their surprising similarities and differences," Cellular and Molecular Life Sciences, vol. 69, no. 15, pp. 2593-2608, 2012.
112. B. O. Zhou, R. Yue, M. M. Murphy, J. G. Peyer, and S. J. Morrison, "Leptin-receptor-expressing mesenchymal stromal cells represent the main source of bone formed by adult bone marrow," Cell Stem Cell, vol. 15, no. 2, pp. 154-168, 2014.
113. D. L. Worthley, M. Churchill, J. T. Compton et al., "Gremlin 1 identifies a skeletal stem cell with bone, cartilage, and reticular stromal potential," Cell, vol. 160, no. 1-2, pp. 269-284, 2015.
114. J. L. Mignone, V. Kukekov, A.-S. Chiang, D. Steindler, and G. Enikolopov, "Neural stem and progenitor cells in nestin-GFP transgenic mice," The Journal of Comparative Neurology, vol. 469, no. 3, pp. 311-324, 2004.
115. F. Balordi and G. Fishell, "Mosaic removal of hedgehog signaling in the adult SVZ reveals that the residual wild-type stem cells have a limited capacity for self-renewal," The Journal of Neuroscience, vol. 27, no. 52, pp. 14248-14259, 2007.
116. P. S. Frenette, S. Pinho, D. Lucas, and C. Scheiermann, "Mesenchymal stem cell: keystone of the hematopoietic stem cell niche and a stepping-stone for regenerative medicine," Annual Review of Immunology, vol. 31, pp. 285-316, 2013.